David Au, ATS 2022: INSIGHT COPD – Investigating a Lifestyle Intervention in Overweight Patients with COPD
touchRESPIRATORY were delighted to speak with Prof. David Au (University of Washington, Seattle, WA, USA) to discuss the findings from the INSIGHT COPD study, investigating a lifestyle intervention in overweight patients with COPD.
‘Intervention Study in Overweight Patients with COPD (INSIGHT COPD): A Pulmonary Trials Cooperative Randomized Clinical Trial.‘ was presented at ATS 2022, 13-18 May 2022.
Questions
- What is known about the association between chronic obstructive pulmonary disease (COPD) and body weight? (0:20)
- Could you give us an overview of the lifestyle intervention you are investigating? (1:07)
- What are the methodology and eligibility criteria of the clinical trial that will evaluate this intervention? (2:21)
- What are the outcome measures of the study? (3:28)
- How well were these achieved? (4:13)
Disclosures: David Au discloses receiving grant/ research support from the Department of Veterans Affairs, NIH and American Lung Association; and honoraria from Boehringer Ingelheim.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones.
Filmed in coverage of the ATS meeting 2022.